Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

PharmEnable Therapeutics is a biopharmaceutical company focused on reimagining small molecule therapeutics through AI. They aim to develop life-changing medicines for cancer and neurological diseases…

PharmEnable Therapeutics is a biopharmaceutical company focused on reimagining small molecule therapeutics through AI. They aim to develop life-changing medicines for cancer and neurological diseases…
Company: PharmEnable
Focus: AI-driven small-molecule drug discovery for oncology and neurology
Proprietary platform: chemSEEK / chemUNIVERSE
Founding origin: University of Cambridge spin-out
Notable financing: $7.5M Pre-Series A (May 22, 2023)
Discovery of small-molecule drugs for cancer and neurological diseases, targeting difficult intracellular and brain targets.
2016
Biotechnology
1.8M
Seed financing announced June 30, 2020
7.5M
Pre-Series A financing to develop next-generation small molecule drugs
“Cambridge Enterprise, MP Healthcare, Parkwalk-managed University of Cambridge Enterprise Fund VI/VIII, Jonathan Milner, Martlet Capital and other corporate/VC/angel investors”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
400+
New This Week